Evidence for Investigating GSK-3 Inhibitors as Potential Therapeutics for Severe COVID-19
Abstract
We revealed that SARS-CoV-2 spike protein induces CXCL10 and GSK-3 inhibitors are potential therapeutics for severe COVID-19.
Keywords:
COVID-19, Cytokine Storm, CXCL10, Spike Protein, Glycogen synthase kinase-3
Status
Graduate
Department
Chemical and Biomolecular Engineering
College
Russ College of Engineering and Technology
Campus
Athens
Faculty Mentor
Goetz, Douglas
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.
COinS
Evidence for Investigating GSK-3 Inhibitors as Potential Therapeutics for Severe COVID-19
We revealed that SARS-CoV-2 spike protein induces CXCL10 and GSK-3 inhibitors are potential therapeutics for severe COVID-19.
Social Media Link
Facebook: Davoud Ghazanfari